• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “inovio-pharmaceuticals” Archives

          in
          Entry Author Date Location
          Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients Sarah Karlin-Smith 07/02/20 National
          Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More Frank Vinluan 04/10/20 National
          Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More Sarah de Crescenzo 03/06/20 National
          14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) Alex Lash 12/22/16 National
          With Government Backing, Moderna Joins the Zika Vaccine Chase Alex Lash 09/07/16 Boston
          Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More Ben Fidler 06/24/16 National
          Heat Biologics, OncoSec Collaborate on Cancer Immunotherapy Frank Vinluan 02/18/15 Raleigh Durham
          OncoSec Medical Advancing Inovio’s Technology Against Cancer Bruce V. Bigelow 02/08/12 San Diego
          Astute Medical Nabs $13M, Roth Capital Hosts Conference, Kaldor Joins Versant, & More San Diego Life Sciences News Bruce V. Bigelow 03/10/11 San Diego
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Sponsored · Whitepaper

            The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars

            IBM Watson
          • Fish & Richardson: Patent Law in Regards to AI and Machine Learning

            Sponsored · Video

            Fish & Richardson: Patent Law in Regards to AI and Machine Learning

            A Fireside Chat with Fish & Richardson Principal Teresa Lavoie

            Fish & Richardson
          • What’s Next in Neuroscience Therapies

            Sponsored · Whitepaper

            What’s Next in Neuroscience Therapies

            New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.